Mirae Asset Global ETFs Holdings’s Vaxcyte PCVX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.93M	Buy	67,741 +3,915	+6%	+$213K	﹤0.01%	957
2026 Q1	$3.69M	Buy	63,826 +2,811	+5%	+$153K	0.01%	919
2025 Q4	$2.81M	Buy	61,015 +187	+0.3%	+$8.36K	﹤0.01%	1007
2025 Q3	$2.18M	Sell	60,828 -16,166	-21%	-$536K	﹤0.01%	1106
2025 Q2	$2.5M	Sell	76,994 -3,087	-4%	-$101K	﹤0.01%	1001
2025 Q1	$3.22M	Buy	80,081 +3,547	+5%	+$284K	0.01%	903
2024 Q4	$6.27M	Buy	76,534 +11,223	+17%	+$1.11M	0.01%	709
2024 Q3	$7.46M	Buy	65,311 +8,055	+14%	+$726K	0.02%	650
2024 Q2	$4.34M	Buy	+57,256	New	+$3.9M	0.01%	789

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PCVX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Vaxcyte (PCVX) stake by 6.1% in Q2 2026, buying an estimated $213K and bringing the position to 67,741 shares worth $3.93M. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Mirae Asset Global ETFs Holdings first reported a position in PCVX in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.46M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 67,741 shares of Vaxcyte worth $3.93M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 3,915 Vaxcyte shares in Q2 2026, an estimated $213K.
Vaxcyte made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #957 holding.
Mirae Asset Global ETFs Holdings first reported a position in Vaxcyte in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Vaxcyte position peaked at $7.46M in Q3 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.